Recombinant Botulinum Toxin Type A for Injection
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Recombinant Botulinum Toxin Type A for Injection, covering 2024-07-24 to 2024-07-24. Get the full timeline:
Most recent: Clinical Trial Update: A Phase III Study to Evaluate the Efficacy and Safety of Recombinant Botulinum Toxin Type A for Injection in the Treatment of Moderate to Severe Glabellar Lines [Phase 3]